首页> 美国卫生研究院文献>Springer Open Choice >Noninvasive Assessment of Coronary Artery Disease in Women: What’s Next?
【2h】

Noninvasive Assessment of Coronary Artery Disease in Women: What’s Next?

机译:女性冠状动脉疾病的无创评估:下一步是什么?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Significant progress in research has been made in the areas of sex-specific aspects of cardiovascular disease. Despite these advances, coronary artery disease (CAD) is the leading cause of death of women in the Western world. Over the past decade, the focused research on women at risk for ischemic heart disease has helped to clarify our understanding of some of the sex-specific factors, which are important in detecting CAD. In women, the detection and evaluation of physiologically significant CAD is challenging, especially given that traditional tests designed to detect focal areas of coronary artery stenosis are less sensitive and specific in female patients who have a lower prevalence of obstructive coronary disease, greater burden of symptoms, and a high atherosclerotic burden. In this article, we review the available evidence on the role of contemporary cardiovascular imaging techniques in evaluating ischemic heart disease in women.
机译:在心血管疾病的性别特定方面,研究取得了重大进展。尽管取得了这些进步,但冠状动脉疾病(CAD)是西方世界女性死亡的主要原因。在过去的十年中,针对处于缺血性心脏病风险中的女性的重点研究有助于阐明我们对某些特定性别因素的理解,这些因素对于检测CAD至关重要。在女性中,具有生理学意义的CAD的检测和评估具有挑战性,特别是考虑到传统的旨在检测冠状动脉狭窄局灶性区域的测试对阻塞性冠状动脉疾病患病率较低,症状负担较大的女性患者的敏感性和特异性较低,以及高的动脉粥样硬化负担。在本文中,我们回顾了有关当代心血管成像技术在评估女性缺血性心脏病中作用的现有证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号